Welcome to our dedicated page for Appyea news (Ticker: APYP), a resource for investors and traders seeking the latest updates and insights on Appyea stock.
AppYea, Inc. (OTCQB: APYP) is a public technology company developing blockchain-based trust infrastructure for regulated, outcome-driven markets. Its news flow documents a strategic pivot around the Techlott platform, a decentralized lottery and gaming engine designed for transparency, verifiable randomness, and real-time outcome verification.
News items for APYP frequently cover corporate transformation milestones, including the acquisition of Techlott’s blockchain technology, integration of that platform into AppYea’s operations, and leadership appointments that align technical ownership with governance. Press releases detail the company’s focus on B2G/B2B deployments for governments, regulators, and institutional operators in lottery, gaming, and prediction markets.
Investors following APYP news can expect updates on technology development and readiness, such as multi-game adaptation of the Techlott engine, multi-chain support, and audit-focused features like on-chain receipts and verifiable randomness workflows. The company also reports on its evaluation of entry into regulated prediction markets and potential introduction of a Techlott network token for system-level functions, while emphasizing regulatory considerations.
Another recurring theme in AppYea’s news is its capital markets and governance roadmap, including internal reviews related to a potential uplisting to a U.S. national securities exchange and a planned rebranding and name change to Mellatrix Inc., subject to approvals. Announcements also highlight institutional engagement, such as advanced-stage discussions with operators and regulators and a Letter of Intent to deploy Techlott infrastructure in a regulated digital gaming and prize-draw environment in The Republic of The Gambia.
This APYP news page aggregates these disclosures so readers can track AppYea’s progress in technology integration, commercial execution, regulatory engagement, and corporate strategy over time.
AppYea Inc. (OTCQB:APYP) announced the immediate addition of Adi Shemer to its advisory board. Shemer has a robust background in operations management within the medical device sector, having held senior executive positions, including CEO at TR bike Ltd. and Tzora Active Systems Ltd. He aims to enhance the production and distribution of AppYea's innovative wearable device, DreamIT, designed to improve sleep quality. The company's focus remains on commercialization, backed by a strong IP portfolio and positive market feedback. This strategic move comes as AppYea transitions from development to commercial operations, indicating growth potential in the sleep health market.
AppYea Inc. (OTCQB:APYP) has appointed Ron Mekler as an independent director and Chair of the Audit Committee, effective immediately. This strategic move aims to enhance the company's board and management using Mekler's extensive experience in finance and healthcare. Mekler previously served as CFO at Clalit Health Services, Israel's largest health organization, and has a robust background in various industries. He expressed confidence in AppYea's potential and its innovative sleep monitoring solutions, which are protected by multiple patents. This leadership change is expected to strengthen the firm's market position and attract partnerships.
SleepX, a subsidiary of AppYea (OTC:APYP), has launched its innovative product DreamIT, a wristband designed to treat sleep apnea and snoring through biofeedback. The initial version has completed testing, with production targeting 20,000 units monthly. Retail price starts at $149, with a holiday discount price of $99. DreamIT monitors vital signs like pulse and blood oxygen, while the accompanying app provides health analytics and alerts. The company is pursuing partnerships with major distributors and considering options with smartphone manufacturers.